| positive regulation of phosphatidylinositol 3-kinase activity |
| epidermal growth factor receptor binding |
| lamellipodium assembly |
| positive regulation of lipid kinase activity |
| phosphotyrosine residue binding |
| lamellipodium organization |
| positive regulation of phospholipid metabolic process |
| regulation of phosphatidylinositol 3-kinase activity |
| regulation of lipid kinase activity |
| vascular endothelial growth factor receptor signaling pathway |
| Rho guanyl-nucleotide exchange factor activity |
| regulation of phospholipid metabolic process |
| ephrin receptor signaling pathway |
| guanyl-nucleotide exchange factor activity |
| immune response-regulating cell surface receptor signaling pathway involved in phagocytosis |
| Fc-gamma receptor signaling pathway involved in phagocytosis |
| Fc receptor mediated stimulatory signaling pathway |
| platelet activation |
| Fc-gamma receptor signaling pathway |
| positive regulation of lipid metabolic process |
| regulation of Rho protein signal transduction |
| Fc-epsilon receptor signaling pathway |
| regulation of cell size |
| Fc receptor signaling pathway |
| regulation of Ras protein signal transduction |
| blood coagulation |
| coagulation |
| hemostasis |
| angiogenesis |
| small GTPase mediated signal transduction |
| phagocytosis |
| regulation of small GTPase mediated signal transduction |
| regulation of cellular component size |
| regulation of lipid metabolic process |
| blood vessel morphogenesis |
| plasma membrane bounded cell projection assembly |
| immune response-activating cell surface receptor signaling pathway |
| cell projection assembly |
| wound healing |
| immune response-regulating cell surface receptor signaling pathway |
| regulation of GTPase activity |
| blood vessel development |
| regulation of body fluid levels |
| transmembrane receptor protein tyrosine kinase signaling pathway |
| vasculature development |
| regulation of anatomical structure size |
| cardiovascular system development |
| immune response-activating signal transduction |
| response to wounding |
| positive regulation of kinase activity |
| immune response-regulating signaling pathway |
| activation of immune response |
| positive regulation of apoptotic process |
| positive regulation of programmed cell death |
| tube morphogenesis |
| positive regulation of transferase activity |
| positive regulation of cell death |
| enzyme linked receptor protein signaling pathway |
| tube development |
| positive regulation of immune response |
| circulatory system development |
| regulation of kinase activity |
| anatomical structure formation involved in morphogenesis |
| cell migration |
| regulation of transferase activity |
| positive regulation of phosphorylation |
| cell activation |
| cell motility |
| localization of cell |
| immune effector process |
| plasma membrane bounded cell projection organization |
| positive regulation of phosphorus metabolic process |
| positive regulation of phosphate metabolic process |
| positive regulation of immune system process |
| regulation of immune response |
| cell projection organization |
| regulation of hydrolase activity |
| locomotion |
| G protein-coupled receptor signaling pathway |
| positive regulation of catalytic activity |
| regulation of apoptotic process |
| movement of cell or subcellular component |
| regulation of programmed cell death |
| regulation of phosphorylation |
| regulation of immune system process |
| regulation of cell death |
| intracellular signal transduction |
| positive regulation of molecular function |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of intracellular signal transduction |
| vesicle-mediated transport |